Milatuzumab
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Milatuzumab, covering 2010-06-02 to 2021-08-16. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Study of Different Doses and Dose Schedules of Milatuzumab (hLL1) in CLL [Phase 1, Phase 2]